GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

We Can Medicines Co 6929.TWO · TWD

Consumer Staples · Taipei Exchange · 🇹🇼 Taiwan

Compare

20.75

+4.01%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About We Can Medicines Co

Its shares trade on Taipei Exchange under the ticker 6929.TWO. It has been listed since 9 December 2022. In the fiscal year to 31 December 2025, it reported revenue of TWD 3.22bn and a net loss of TWD 73.2m. At that date it held total assets of TWD 2.98bn and shareholders' equity of TWD 1.05bn.

We Can Medicines Co., Ltd. engages in the sale of medicines, health food, maternity and baby products, and medical equipment. The company is headquartered in Taichung, Taichung. The company went IPO on 2022-12-09. The firm's main products include pharmaceuticals and health food, maternity and infant products, medical supplies, beauty cosmetics and daily necessities. The firm also provides paper products and diapers. Other labor income comes from pharmacy management fees and royalties. The firm mainly provides its goods in Taiwan.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Consumer Staples Distribution & Retail
Listed since
9 Dec 2022

Leadership

Pay as last reported

  • Mr. Zhiping LiuChairman of the Board, since 2008
  • Mr. Tzu-Ting FanVice Chairman of the Board, since 2024
  • Huijun LiuManager of Finance & Accounting
  • Ms. Delan WenGeneral Manager, Director, since 2017
  • Ms. Shujuan ZhangCorporate Governance Officer, Director, since 2022
  • Ms. Tsuey-Wen YehDirector
  • Hongyun ChenIndependent Director
  • Zongchao HanIndependent Director
  • Xiuzhu OuIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Taichung, Taiwan, with a focus on consumer staples retail.
  • Offers a diverse product range including medicines, health food, and maternity products.
  • Generates additional revenue from pharmacy management fees and royalties.

Weaknesses

  • Reliance on the Taiwan market for all product sales.
  • Limited product diversity beyond pharmaceuticals and health-related items.
  • Dependent on a single industry sector for revenue streams.

Opportunities

  • Expansion into new markets beyond Taiwan for product distribution.
  • Potential to diversify product offerings to include more non-health-related items.
  • Growth in demand for health and wellness products in Taiwan.

Threats

  • Competition from other pharmaceutical and retail companies in Taiwan.
  • Economic downturns affecting consumer spending on non-essential health products.
  • Regulatory changes impacting the pharmaceutical industry in Taiwan.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.